The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shchepankevich L.A.

Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia

Tanashyan M.M.

Neurology Research Center, Moscow, Russia

Nikolaev Yu.A.

Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia

Polyakov V.Ya.

Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia

Pervuninskaya M.A.

Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia

Antonova K.V.

Neurology Research Center, Moscow, Russia

Role of antioxidants in treatment and prevention of patients with high risk of cardiovascular complications

Authors:

Shchepankevich L.A., Tanashyan M.M., Nikolaev Yu.A., Polyakov V.Ya., Pervuninskaya M.A., Antonova K.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2018;11(4): 31‑35

DOI: 10.17116/kardio201811431

Read: 2208 times

Download PDF (RU)
Contact the author
Table of contents

ROLE OF ANTIOXIDANTS IN TREATMENT AND PREVENTION OF PATIENTS WITH HIGH RISK OF CARDIOVASCULAR COMPLICATIONS
ROLE OF ANTIOXIDANTS IN TREATMENT AND PREVENTION OF PATIENTS WITH HIGH RISK OF CARDIOVASCULAR COMPLICATIONS

To cite this article:

Shchepankevich LA, Tanashyan MM, Nikolaev YuA, Polyakov VYa, Pervuninskaya MA, Antonova KV. Role of antioxidants in treatment and prevention of patients with high risk of cardiovascular complications. Russian Journal of Cardiology and Cardiovascular Surgery. 2018;11(4):31‑35. (In Russ.)
https://doi.org/10.17116/kardio201811431

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Modern approaches to diagnosis and treatment of syndrome of auto­nomic dysfunction in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):66-75
Proton pump inhi­bitors: posi­tive and nega­tive properties. On the 45th anni­versary of their discovery. Russian Journal of Preventive Medi­cine. 2024;(11):135-140
Study of opinions of medi­cal students on medi­cal prevention issues. Russian Journal of Preventive Medi­cine. 2024;(12):69-74
Asse­ssment of risk of deve­loping fractures and sarcopenia and quality of life of patients with chro­nic kidney disease at the outpatient stage. Russian Journal of Preventive Medi­cine. 2024;(12):88-91
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Prevention of periodontal inflammation in microgravity mode­ling. Stomatology. 2024;(6-2):23-28
Effe­ctiveness of risk-guided cardiac mana­gement in patients with HER2-positive breast cancer and cancer therapy-related cardiac dysfunction. Russian Cardiology Bulletin. 2024;(4-2):144-153
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114
Abstract:

Aim — to estimate effect of Mexidol on blood lipids in patients with high cardiovascular risk and diabetes mellitus type 2 (DM2). Material and methods. Two groups of patients with DM2 as the main risk factor of vascular complications were prospectively followed-up within 3 months. Achievement of target blood lipid was compared in standard therapy with statins (group 1) and addition of Mexidol to basic therapy (group 2). Enzymatic colorimetric method was used to determine blood lipids level (Boehringer Mannheim, Germany). Results. There was a positive effect of Mexidol at the initial stage of statins therapy that was expressed by normalized lipids level in DM2 patients with high and very high cardiovascular risk.

Keywords:

cardiovascular complications
diabetes mellitus type 2
dyslipidemia
prevention
Mexidol

Authors:

Shchepankevich L.A.

Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia

Tanashyan M.M.

Neurology Research Center, Moscow, Russia

Nikolaev Yu.A.

Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia

Polyakov V.Ya.

Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia

Pervuninskaya M.A.

Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia

Antonova K.V.

Neurology Research Center, Moscow, Russia

Close metadata

References:

  1. WHO, Cardiovascular diseases, Fact sheet №317, January 2015. (In Russ.) http://www.who.int/mediacentre/factsheets/fs317/ru
  2. Russian National Society of Cardiology. National recommendations. Efficacy and safety of drug therapy in primary and secondary prevention of cardiovascular disease. M. 2011. (In Russ.)
  3. Shalnova SA, Konradi AO, et al. Analysis of mortality from cardiovascular diseases in 12 regions of the Russian Federation participating in the study “Epidemiology of cardiovascular diseases in various regions of Russia». Rossiiskyi Cardiologicheskii Zhurnal. 2012;5(97):6-11. (In Russ.)
  4. Oganov RG, Kontsevaya AV, Kalinina AM. Economic damage from cardiovascular diseases in the Russian Federation. Cardiovascularnaya therapya i profilaktika. 2011;10(4):4-9. (In Russ.)
  5. Oganov RG. The concept of risk factors as the basis for the prevention of cardiovascular diseases. Vrach. 2001;7:3-6. (In Russ.)
  6. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM). European Heart Journal. 1998;19(Suppl. A):A2-A11, Castelli W, Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingam study. Am J Med. 1986;80(Suppl 2A):23-32.
  7. Song SH. Early-onset type 2 diabetes: high lifetime risk for cardiovascular disease. Lancet Diabetes Endocrinol. 2015 Dec 15.
  8. Diagnosis and correction of lipid metabolism disorders for the purpose of prevention and treatment of atherosclerosis. Recommendations of the RNSC. M. 2005;9-14. (In Russ.)
  9. ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2011;32:1769-1818.
  10. Diagnosis and correction of lipid metabolism disorders for the purpose of prevention and treatment of atherosclerosis. Russian recommendations V revision. Atherosclerosis and dyslipidemiya. 2012;9:5-51. (In Russ.)
  11. Cardiovascular prevention. National recommendations. Appendix 2 to the journal Cardiovascularnaya Therapya i Profilaktika. 2011;10(6). (In Russ.)
  12. Dedov II, Shestakova MV, Vikulova O.K. State Register of Diabetes Mellitus in the Russian Federation: Status of 2014 and Prospects for Development. Sacharny Diabet. 2015;18(3):5-23. (In Russ.) https://doi.org/10.14341/DM201535-22
  13. Howangyin KY, Silvestre JS. Diabetes mellitus and ischemic diseases: molecular mechanisms of vascular repair dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology. 2014;34(6):1126-1135. https://doi.org/10.1161/atvbaha.114.303090
  14. Tanashyan MM, Shchepankevich LA, Orlov SV, et al. Hemorheology and hemostasis in patients with ischemic stroke in the background of type 2 diabetes mellitus and metabolic syndrome. Annaly clinicheskoy i experimentalnoy nevrologii. 2014;3:14-20. (In Russ.)
  15. Rydén L, et al. Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28:88-136.
  16. Shchepankevich LA, Nikolaev YuA, et al. Optimization of lipid-lowering therapy in patients with ischemic stroke and type 2 diabetes. Zhurnal nevrologii I psikhiatrii im. S.S. Korsakova. 2016;2:42-45. (In Russ.) https://doi.org/10.17116/jnevro20161162142-45
  17. Klimov AN, Nikulcheva NG. Exchange of lipids and lipoproteins and its violation: a guide for doctors. St. Petersburg: Peter-Com; 1999. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.